Literature DB >> 18475483

Role of interleukin-1 and tumour necrosis factor in leukocyte recruitment to acute dermal inflammation.

A C Issekutz1, N Lopes, T B Issekutz.   

Abstract

The cytokines IL-1 and TNF-alpha are involved in inflammation and their production is stimulated by various agents, especially endotoxin (LPS). Here, using the human IL-1 receptor antagonist (IL-1RA) and a new monoclonal antibody (mAb 7F11) to rabbit TNF, the role of endogenous IL-l and TNF production in acute (3h) leukocyte (PMNL) recruitment to dermal inflammation in rabbits has been studied. IL-1RA inhibited by 27% the PMNL accumulation in reactions induced by killed Escherichia coli (p < 0.05) but not by LPS. The monoclonal antibody to TNF inhibited by 27% and 38% (p < 0.002) the PMNL accumulation in LPS and E. coli reactions respectively, but a combination of the mAb with IL-1RA was not more effective. Treatment of human umbilical vein endothelium with LPS for 3 h activated endothelium to induce PMNL transendothelial migration in vitro, which was not inhibited by IL-1RA, antibody to TNF-alpha, IL-1 or to IL-8. In conclusion, TNF and IL-1 may partially mediate acute PMNL infiltration in vivo to LPS and Gram negative bacteria, but there is a major IL-1/TNF independent mechanism, at least in dermal inflammation, which may be due to direct LPS activation of the microvasculature or perhaps the generation of cytokines other than IL-1 and TNF.

Entities:  

Year:  1992        PMID: 18475483      PMCID: PMC2365361          DOI: 10.1155/S0962935192000528

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  27 in total

Review 1.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  Cytokines and endothelial cell biology.

Authors:  J S Pober; R S Cotran
Journal:  Physiol Rev       Date:  1990-04       Impact factor: 37.312

3.  Role for endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation.

Authors:  A C Issekutz; S Bhimji
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

4.  Antibodies to thymopoietin following implantation of paper disks derivatized with synthetic Cys-thymopoietin.

Authors:  G I Viamontes; T Audhya; G Goldstein
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

5.  The in vivo quantitation and kinetics of rabbit neutrophil leukocyte accumulation in the skin in response to chemotactic agents and Escherichia coli.

Authors:  A C Issekutz; H Z Movat
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

6.  Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.

Authors:  A C Issekutz; S Bhimji; R Bortolussi
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5ades arg: probable role of polymorphonuclear leucocyte lysosomes.

Authors:  A C Issekutz; K W Movat; H Z Movat
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

8.  Role for macrophage products in endotoxin-induced polymorphonuclear leukocyte accumulation during inflammation.

Authors:  A C Issekutz; P Megyeri; T B Issekutz
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

9.  The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation.

Authors:  T R Ulich; S M Yin; K Z Guo; J del Castillo; S P Eisenberg; R C Thompson
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

10.  Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.

Authors:  K W McIntyre; G J Stepan; K D Kolinsky; W R Benjamin; J M Plocinski; K L Kaffka; C A Campen; R A Chizzonite; P L Kilian
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  1 in total

1.  Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.

Authors:  Wesley Solomon; Nana O Wilson; Leonard Anderson; Sidney Pitts; John Patrickson; Mingli Liu; Byron D Ford; Jonathan K Stiles
Journal:  J Neuroinflammation       Date:  2014-01-17       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.